Skip to content

ATYR PHARMA, INC.

ATYR

CIK 0001339970

← back to feed
Revenue (TTM)
$190K
−19.1% YoY Q1 May 2026
Net Income (TTM)
−$70.95M
−15.8% YoY Q1 May 2026
EPS Diluted (TTM)
−$0.76
+7.0% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
-39,087.9%
Q1 May 2026
Net Margin
-37,340.0%
Q1 May 2026
Free Cash Flow (TTM)
−$52.31M
Q1 May 2026
Cash
$10.01M
Q1 May 2026
Total Debt
$5.8M
Q1 May 2026
Shares Outstanding
98.05M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings